(Q28208736)

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Postpartum preeclampsia management with furosemide: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

Hypertension in pregnancy: the incidence of underlying renal disease and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0030-Y

The use of calcium-channel blockers in pregnancy.

21 January 2018

1 reference

12 December 2020

Increased cerebral blood flow in preeclampsia with magnetic resonance imaging

1 reference

12 December 2020

Labetalol decreases cerebral perfusion pressure without negatively affecting cerebral blood flow in hypertensive gravidas

1 reference

12 December 2020

Drugs for treatment of very high blood pressure during pregnancy.

1 reference

12 December 2020

Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

1 reference

12 December 2020

Pre-eclampsia: more than pregnancy-induced hypertension

1 reference

12 December 2020

World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women

1 reference

12 December 2020

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

12 December 2020

Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies

1 reference

12 December 2020

Hypertensive drugs in pregnancy. Antihypertension therapy in pregnancy, preeclampsia, and eclampsia

1 reference

12 December 2020

Administration time-dependent influence of aspirin on blood pressure in pregnant women

1 reference

12 December 2020

Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia

1 reference

12 December 2020

New insights into the genetics of preeclampsia

1 reference

12 December 2020

Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients

1 reference

12 December 2020

Role of the renin-angiotensin system in the pathogenesis of preeclampsia

1 reference

12 December 2020

Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease

1 reference

12 December 2020

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.

1 reference

12 December 2020

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

1 reference

12 December 2020

Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries

1 reference

12 December 2020

Calcium supplementation to prevent hypertensive disorders of pregnancy

1 reference

12 December 2020

A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension

1 reference

12 December 2020

CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group

1 reference

12 December 2020

Vascular endothelial growth factor induces endothelial fenestrations in vitro

1 reference

12 December 2020

Trial of calcium to prevent preeclampsia

1 reference

12 December 2020

Pre-eclampsia in pregnancy and subsequent risk for breast cancer

1 reference

12 December 2020

The role of nitric oxide in the pathogenesis of preeclampsia

1 reference

12 December 2020

Recent advances in the management of preeclampsia

1 reference

12 December 2020

Abnormal endothelial cell function of resistance arteries from women with preeclampsia

1 reference

12 December 2020

Calcium-to-creatinine ratio in spot urine samples in early pregnancy and its relation to the development of preeclampsia

1 reference

12 December 2020

Diagnosis and management of gestational hypertension and preeclampsia

1 reference

12 December 2020

Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

1 reference

12 December 2020

A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy

1 reference

12 December 2020

Comprehensive management of hypertensive emergencies and urgencies

1 reference

12 December 2020

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia

1 reference

12 December 2020

Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation

1 reference

12 December 2020

The treatment of hypertension in pregnancy.

1 reference

12 December 2020

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

1 reference

12 December 2020

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

1 reference

12 December 2020

Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches

1 reference

12 December 2020

Pharmacologic approaches for the management of systemic hypertension in pregnancy

1 reference

12 December 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

12 December 2020

Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin

1 reference

12 December 2020

Pregnancy spacing and maternal morbidity in Matlab, Bangladesh.

1 reference

12 December 2020

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

1 reference

12 December 2020

Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients

1 reference

12 December 2020

Preeclampsia: a renal perspective

1 reference

12 December 2020

Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia

1 reference

12 December 2020

Long-term outcomes after preeclampsia

1 reference

12 December 2020

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

1 reference

12 December 2020

The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy

1 reference

12 December 2020

L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat.

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Diagnosis and management of chronic hypertension in pregnancy

1 reference

12 December 2020

Management of pre-eclampsia

1 reference

12 December 2020

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

12 December 2020

Parameters associated with adverse perinatal outcome in hypertensive pregnancies

1 reference

12 December 2020